PRECLINICAL DRUG DEVELOPMENT PARADIGMS FOR CHEMOPREVENTIVES
- 1 October 1998
- journal article
- review article
- Published by Elsevier in Hematology/Oncology Clinics of North America
- Vol. 12 (5), 943-961
- https://doi.org/10.1016/s0889-8588(05)70035-6
Abstract
No abstract availableKeywords
This publication has 58 references indexed in Scilit:
- Rapid induction of mammary intraductal proliferations, ductal carcinoma in situ and carcinomas by the injection of sexually immature female rats with 1-methyl-1-nitrosoureaCarcinogenesis: Integrative Cancer Research, 1995
- Ornithine decarboxylase as a target for chemopreventionJournal of Cellular Biochemistry, 1995
- Chemopreventive properties and mechanisms ofN-acetylcysteine. The experimental backgroundJournal of Cellular Biochemistry, 1995
- Signalling pathways as target for anticancer drug developmentPharmacology & Therapeutics, 1994
- New trends in photobiologyJournal of Photochemistry and Photobiology B: Biology, 1992
- Mechanisms of inhibition of free-radical processes in mutagenesis and carcinogenesisMutation Research, 1988
- Mammary cancer chemoprevention by inorganic and organic selenium: single agent treatment or in combination with vitamin E and their effects on in vitro immune functionsCarcinogenesis: Integrative Cancer Research, 1987
- Studies on ergothioneine. XI. Inhibitory effect on lipid peroxide formation in mouse liver.CHEMICAL & PHARMACEUTICAL BULLETIN, 1983
- RETINOIDS INHIBIT PROMOTER‐DEPENDENT PRENEOPLASTIC PROGRESSION IN MOUSE EPIDERMAL CELL LINESAnnals of the New York Academy of Sciences, 1981
- Influence of total dose and dose schedule on induction of urinary bladder cancer in the mouse by N-butyl-N-(4-hydroxy-butyl)nitrosamineCarcinogenesis: Integrative Cancer Research, 1981